세계의 안과용 초음파 시스템 시장 : 인사이트, 경쟁 구도, 예측(2032년)

Ophthalmic Ultrasound Systems Market Summary

• The global ophthalmic ultrasound systems market is expected to increase from USD 612.48 million in 2024 to USD 918.54 million by 2032, reflecting strong and sustained growth.
• The global ophthalmic ultrasound systems market is growing at a CAGR of 5.28% during the forecast period from 2025 to 2032.
• The global ophthalmic ultrasound systems market is growing due to the rising prevalence of eye disorders like cataracts, glaucoma, and retinal diseases, especially in the aging population. Advancements in portable devices, high-resolution imaging, and AI integration are boosting adoption for accurate, minimally invasive diagnostics. Additionally, expanding healthcare access in emerging economies and increasing routine eye screenings are further driving market demand.
• The leading companies operating in the ophthalmic ultrasound systems market include Sonomed Escalon, Lumibird Medical, DGH Technology, Inc., NIDEK CO., LTD., Topcon Corporation, Accutome Inc., Appasamy Associates Private Limited, Eye-Tech Inc., Micro Medical Devices (MMD), Inc., TOMEY CORPORATION, MEDA Co., Ltd., and others.
• The North America ophthalmic ultrasound systems market is a dominant force globally, driven by the high prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy, coupled with a rapidly aging population. Strong healthcare infrastructure, widespread adoption of advanced diagnostic technologies, and favorable reimbursement policies further support market expansion. Additionally, the presence of leading medical device manufacturers and increasing demand for early, accurate diagnosis of vision-related diseases are driving growth in the region.
• In the product type segment of the ophthalmic ultrasound systems market, the ultrasound systems category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Ophthalmic Ultrasound Systems Market

• Rising prevalence of ocular diseases leading to a surge in the ophthalmic ultrasound systems market: The growth of the ophthalmic ultrasound market is fundamentally intertwined with the global epidemiological trends of major eye diseases. These conditions are not only increasing in prevalence but also creating a specific demand that ultrasound technology is uniquely suited to address.
• Cataracts remain the leading cause of preventable blindness worldwide. The World Health Organization (WHO) estimates that cataracts are responsible for a significant portion of global vision impairment. The prevalence is strongly linked to age, and as the global population continues to age, the number of cataract cases is projected to rise dramatically.
• As the global prevalence of diabetes reaches epidemic proportions, so does its most serious microvascular complication: diabetic retinopathy (DR). Long-term duration and poor glycemic control in diabetic patients significantly increase the risk of developing DR. This condition is the leading cause of blindness among working-age adults in many countries.
• Glaucoma, known as the "silent thief of sight," often presents without symptoms in its early stages. It is the second leading cause of irreversible blindness globally. The number of people with glaucoma is expected to grow, particularly in older populations.
• Expanding Geriatric Population: The world's aging population is a major driver, as older individuals are more susceptible to chronic eye conditions. The need for continuous monitoring and evaluation of these conditions safely and cost-effectively makes ophthalmic ultrasound systems a preferred tool.
• Advancements in imaging technology:
• Improved Imaging: Ongoing advancements have led to higher-resolution imaging, allowing for clearer and more detailed visualization of ocular structures.
• Portability: The development of compact, portable, and handheld devices is expanding access to diagnostic services, especially in clinics with limited space and in rural or underserved regions.
• Integration with AI: The integration of artificial intelligence (AI) and deep-learning algorithms enhances diagnostic accuracy and efficiency, often providing results comparable to those of expert clinicians.
• Multifunctional Systems: The market is seeing a trend toward multifunctional systems that combine speed, precision, and connectivity, making them more versatile for different applications.

Ophthalmic Ultrasound Systems Market Report Segmentation

This ophthalmic ultrasound systems market report offers a comprehensive overview of the global ophthalmic ultrasound systems market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation of the Ophthalmic Ultrasound Systems Market by Product (A-scan, B-scan, Combined, Pachymeter, and Ultrasound Bio microscope), Modality (Portable, Standalone), End-Users (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing ophthalmic ultrasound systems market.

An ophthalmic ultrasound system is a medical diagnostic instrument used in ophthalmology to create images of the eye and its surrounding structures using high-frequency sound waves. This non-invasive and painless procedure is often referred to as ocular ultrasonography or eye echography. The device works on the principle of sonar. A small probe, known as a transducer, is placed on the eyelid or directly on the surface of the eye. This probe emits sound waves that travel into the eye. When these waves encounter different tissues and structures, they bounce back as echoes. The device captures these echoes and converts them into a detailed image on a monitor, which the ophthalmologist can then analyze.

The ophthalmic ultrasound systems market is witnessing steady growth due to the rising prevalence of eye disorders such as cataracts, glaucoma, retinal detachment, and age-related macular degeneration, particularly among the aging population. Increasing awareness of early diagnosis and the importance of advanced imaging techniques in ophthalmology is further driving adoption. Technological advancements, including portable and handheld ultrasound systems, improved image resolution, and integration with AI for enhanced diagnostic accuracy, are expanding their clinical utility. Additionally, the growing demand for minimally invasive diagnostic procedures and cost-effective imaging solutions supports market expansion. Favourable reimbursement policies in developed regions and rising healthcare infrastructure investments in emerging economies are also contributing to growth. Furthermore, the increase in routine eye examinations due to diabetes and other systemic conditions continues to boost demand for ophthalmic ultrasound systems.

What are the latest Ophthalmic Ultrasound Systems Market Dynamics and Trends?

The primary driver for ophthalmic ultrasound systems lies in their indispensable diagnostic role when the internal ocular media are opaque. While advanced imaging technologies like Optical Coherence Tomography (OCT) provide high-resolution visualization in eyes with clear media, they are ineffective when light cannot penetrate the eye's structures. In such cases, ultrasound, which uses sound waves, becomes the only viable option for evaluating the posterior segment.

Key Clinical Applications:

• Imaging in Opaque Media: Dense cataracts, significant vitreous hemorrhage, or severe corneal opacities can block direct visualization of the retina and optic nerve. In these situations, B-scan ultrasound allows clinicians to diagnose:
• Retinal detachment - detecting separation of the retina requiring urgent surgery.
• Vitreous hemorrhage - evaluating bleeding due to advanced diabetic retinopathy.
• Intraocular tumors - identifying and characterizing lesions hidden from direct view.
• Intraocular foreign bodies - localizing traumatic objects for surgical removal.
• Ocular Biometry for Surgical Planning: A-scan ultrasound is critical for measuring the axial length of the eye, which is essential for calculating intraocular lens (IOL) power in cataract surgery. Given the global surge in cataract procedures, estimated at over 30 million annually worldwide and projected to increase with population aging, the demand for A-scan devices continues to rise in tandem.

Diabetic retinopathy (DR) remains a leading cause of blindness globally, and its complications frequently require ultrasound evaluation.

• Vitreous Hemorrhage: Fragile neovascular vessels in advanced DR often rupture, causing dense hemorrhage that blocks retinal visualization. Ultrasound is essential before surgical planning to assess the retina's condition.
• Retinal Traction & Detachment: Ultrasound helps evaluate tractional forces from proliferative DR that can detach the retina.

With diabetes prevalence expected to reach 643 million adults by 2030 and 783 million by 2045 (IDF), the number of patients with advanced DR and related complications will surge, sustaining long-term demand for ophthalmic ultrasound systems.

Beyond clinical applications, broad demographic shifts underpin market expansion:

• Aging Population: The UN projects that the global population aged 65+ will rise from 761 million in 2021 to 1.6 billion by 2050. Older adults are disproportionately affected by chronic eye diseases such as cataract, age-related macular degeneration (AMD), glaucoma, and presbyopia, all conditions that may necessitate ultrasound imaging when standard modalities fall short.
• Rising Vision Impairment: Over 2.2 billion people currently experience vision impairment or blindness, with projections suggesting 1.5-1.7 billion will be affected by 2050. This mounting burden drives sustained demand for non-invasive, repeatable imaging and monitoring technologies.
• Comorbidities: The rising global prevalence of systemic conditions like diabetes and hypertension contributes to higher rates of ocular complications requiring advanced imaging support.

Taken together, these factors, an aging population, the growing burden of vision impairment, and the surge in chronic diseases like diabetes, create a strong demographic and clinical imperative for ophthalmic ultrasound. Unlike optical imaging systems, ultrasound maintains its value where traditional diagnostics fail, making it an essential tool in ophthalmologists' armamentarium. Furthermore, its adaptability across care settings (hospitals, specialized clinics, and community-based eye care) positions ophthalmic ultrasound systems as a cost-effective, indispensable solution in the expanding global eye care landscape.

Ophthalmic Ultrasound Systems Market Segment Analysis

Ophthalmic Ultrasound Systems Market by Product (A-scan, B-scan, Combined, Pachymeter, and Ultrasound Bio microscope), Modality (Portable, Standalone), End-Users (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product: A-scan Category Dominates the Market

The A-scan category represents the dominant segment in the ophthalmic ultrasound systems market, accounting for a substantial share of approximately 30% in 2024. The dominance of the A-scan category in the ophthalmic ultrasound market is underpinned by its critical, non-negotiable role in pre-operative cataract surgery, one of the most frequently performed surgical procedures worldwide. With more than 30 million cataract surgeries performed annually across the globe, a figure projected to increase steadily as populations age, the demand for accurate and reliable A-scan biometry remains consistently high.

A-scan ultrasound provides the precise axial length measurement required to calculate the power of intraocular lenses (IOLs), a decisive factor in achieving optimal visual outcomes post-surgery. Even as optical biometers become more common in high-income regions, A-scan retains its indispensability:

Backup Role: In patients with dense cataracts, corneal opacities, or vitreous hemorrhages, optical biometers cannot provide accurate readings, making A-scan the only viable tool.

Clinical Necessity: Virtually every ophthalmology clinic and hospital that performs cataract surgery requires A-scan technology, reinforcing its foundational role in surgical planning.

Beyond high-income markets, A-scan adoption is further bolstered by the availability of cost-effective, portable devices, which make the technology accessible to a broad spectrum of providers. This is particularly important in emerging economies, where cataract remains the leading cause of preventable blindness and the demand for affordable, reliable pre-surgical assessment tools is especially strong. Portable A-scan systems enable outreach programs and smaller private practices to deliver high-quality cataract care, bridging gaps in access and supporting large-scale national eye health initiatives.

As a result, the A-scan category is not only dominant today but is also expected to maintain its leadership in the ophthalmic ultrasound market, supported by the dual forces of global surgical volume growth and the universal requirement for accurate biometry in cataract care.

By Modality: Standalone Category Dominates the Market

The standalone category represents the dominant segment in the ophthalmic ultrasound systems market, accounting for a substantial share of approximately 60% in 2024. Non-portable or standalone, console-based ophthalmic ultrasound systems continue to dominate the market due to their superior performance, reliability, and integration within clinical workflows. Equipped with high-frequency transducers, advanced processors, and multifunctional capabilities such as A-scan, B-scan, UBM, and pachymetry, these systems deliver unmatched image quality and diagnostic confidence in complex cases like intraocular tumors, severe retinal detachments, and advanced vitreous hemorrhages. Built for durability and continuous high-volume use, they are widely adopted in hospitals and specialty centers, supported by robust service networks and seamless integration with EMR/EHR and PACS systems. Their long-standing role as the standard of care has entrenched them in ophthalmology practice, ensuring continued preference among clinicians. While portable and handheld devices are gaining traction in smaller practices and outreach programs, console-based systems remain indispensable in advanced care settings, securing their dominance in the global ophthalmic ultrasound market.

By End-Users: Hospitals Dominate the Market

The hospital category held the largest market share, capturing nearly 50% of the global market in 2024. The hospital category holds the largest market share in the ophthalmic ultrasound market because hospitals serve as the primary centers for diagnosing and managing complex eye conditions that require advanced imaging capabilities. High patient volumes, particularly for cataract surgeries, retinal disorders, and ocular trauma, drive consistent demand for A-scan and B-scan ultrasounds in hospital settings.

Hospitals also handle the most complicated cases, such as intraocular tumors, severe retinal detachments, or vitreous hemorrhages, where console-based ultrasound systems provide superior diagnostic accuracy. In addition, hospitals benefit from better infrastructure, higher budgets, and established integration with EMR/EHR and PACS systems, allowing them to adopt multifunctional, high-end ultrasound platforms. Their role as referral centers and surgical hubs further strengthens their dominance, as smaller clinics often direct patients with advanced or surgical needs to hospitals, consolidating ultrasound utilization in this setting.

Ophthalmic Ultrasound Systems Market Regional Analysis

North America Ophthalmic Ultrasound Systems Market Trends

North America, led by the United States, dominates the global ophthalmic ultrasound systems market, accounting for approximately 40% of the total market share in 2024. The dominance is due to a combination of strong clinical demand, robust healthcare infrastructure, and favorable demographics, supported by high surgical volumes, with the U.S. alone performing nearly 3.8 million cataract surgeries annually that drive consistent demand for A-scan biometry.

Population aging further amplifies this need, as the number of Americans aged 65+ is projected to rise from about 58 million in 2022 to more than 82 million by 2050, leading to a higher prevalence of cataract, glaucoma, and age-related macular degeneration. Additionally, over 38 million Americans live with diabetes, fueling cases of diabetic retinopathy and vitreous hemorrhage that require B-scan ultrasound for diagnosis and surgical planning.

Hospitals and specialty eye centers in the region are well equipped with advanced infrastructure and reimbursement systems, favoring the adoption of high-end, console-based ultrasound platforms that offer multimodal capabilities, PACS/EMR integration, and durability for high-volume use. Combined with the strong presence of key industry players and ongoing product innovation, these factors solidify North America's leadership in the global ophthalmic ultrasound systems market.

Europe Ophthalmic Ultrasound Systems Market Trends

Europe holds a strong position in the global ophthalmic ultrasound devices market, supported by a combination of demographic shifts, high cataract surgery volumes, and well-established healthcare infrastructure. The region's aging population is a major driver: by 2050, more than 30% of Europeans will be aged 65 years or older, significantly increasing the prevalence of cataract, glaucoma, and age-related macular degeneration (AMD), all of which necessitate frequent diagnostic imaging.

Europe already performs millions of cataract surgeries annually, with countries like Germany, France, and the UK among the highest surgical volume markets, creating steady demand for A-scan biometry. The prevalence of diabetes is also rising across the region, with over 60 million adults living with the disease, making diabetic retinopathy a growing concern and reinforcing the role of B-scan ultrasound in managing advanced complications like vitreous hemorrhage and retinal detachment.

Unlike North America, Europe's market is shaped by publicly funded healthcare systems and cost-conscious procurement, which drives adoption of both high-end console systems in tertiary centers and more affordable standalone A-scan units in smaller practices. Furthermore, Europe is home to several leading ophthalmic device manufacturers and research hubs, fostering innovation and faster integration of advanced imaging technologies.

Together, these factors position Europe as a mature yet steadily growing market, where the combination of rising elderly populations, chronic disease burden, and strong clinical infrastructure continues to sustain demand for ophthalmic ultrasound systems.

Asia-Pacific Ophthalmic Ultrasound Systems Market Trends

Asia-Pacific is emerging as the fastest-growing region in the ophthalmic ultrasound systems market, driven by its massive population base, rapid aging, and high burden of cataract and diabetes-related eye diseases. The region is home to more than 60% of the global population, and by 2050, Asia alone will account for over 1.2 billion people aged 60 years and older, creating a disproportionately large patient pool for age-related conditions such as cataract, glaucoma, and AMD.

Cataract remains the leading cause of blindness in many Asia-Pacific countries, and with tens of millions of procedures performed annually, the demand for reliable A-scan biometry is particularly strong. At the same time, the diabetes epidemic is accelerating across the region, with countries like India and China together accounting for nearly one-third of the world's diabetic population, leading to rising cases of diabetic retinopathy that increase reliance on B-scan ultrasound for diagnosis and surgical planning.

Unlike North America and Europe, much of the Asia-Pacific market is still developing, with limited access to advanced ophthalmic care in rural areas; this has created a strong niche for cost-effective, portable, and standalone ultrasound devices, especially in outreach programs and smaller private practices. However, large tertiary hospitals in major cities are increasingly adopting high-end console-based ultrasound systems to manage complex cases and integrate with expanding digital health infrastructure.

Overall, Asia-Pacific combines the world's largest patient pool with rising healthcare investments, making it the most dynamic growth engine for the global ophthalmic ultrasound systems market.

Who are the major players in the Ophthalmic Ultrasound Systems Market?

The following are the leading companies in the Ophthalmic Ultrasound Systems market. These companies collectively hold the largest market share and dictate industry trends.

• Sonomed Escalon
• Lumibird Medical
• DGH Technology, Inc.
• NIDEK CO., LTD.
• Topcon Corporation
• Accutome Inc.
• Appasamy Associates Private Limited
• Eye-Tech Inc.
• Micro Medical Devices (MMD), Inc.
• TOMEY CORPORATION
• MEDA Co., Ltd.
• Others

How is the competitive landscape shaping the Ophthalmic Ultrasound Systems Market?

The competitive landscape of the ophthalmic ultrasound market is characterized by a moderate level of concentration, with several established global and regional players holding significant market share. The competitive dynamic is shaped by a blend of technological innovation, strategic partnerships, and geographic expansion. Key players such as Quantel Medical, Sonomed Escalon, and NIDEK Co. Ltd., among others, focus on product differentiation by offering advanced features like AI integration and 3D imaging to enhance diagnostic accuracy and efficiency. At the same time, the increasing demand for portable and cost-effective solutions in emerging economies is fostering competition from smaller, specialized manufacturers. This is compelling larger companies to invest in R&D for more compact and accessible devices, while also leveraging strategic mergers and acquisitions to broaden their product portfolios and strengthen their global footprint. Ultimately, the market is defined by a race to provide highly accurate, user-friendly, and cost-effective solutions that cater to the evolving needs of both large hospital networks and smaller clinics worldwide.

Recent Developmental Activities in the Ophthalmic Ultrasound Systems Market

• In May 2024, Quantel Medical POCKET III, a new handheld pachymeter, a device used to measure corneal thickness, was launched. This product is part of a series of updates to the company's ultrasound portfolio.

Ophthalmic Ultrasound Systems Market Segmentation

• Ophthalmic Ultrasound Systems by Product Exposure
• A-scan
• B-scan
• Combined
• Pachymeter
• Ultrasound Bio microscope
• Ophthalmic Ultrasound Systems Modality Exposure
• Portable
• Standalone
• Ultrasound Systems End-Users Exposure
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Ophthalmic Ultrasound Systems Geography Exposure
• North America Ophthalmic Ultrasound Systems Market
• United States Ophthalmic Ultrasound Systems Market
• Canada Ophthalmic Ultrasound Systems Market
• Mexico Ophthalmic Ultrasound Systems Market
• Europe Ophthalmic Ultrasound Systems Market
• United Kingdom Ophthalmic Ultrasound Systems Market
• Germany Ophthalmic Ultrasound Systems Market
• France Ophthalmic Ultrasound Systems Market
• Italy Ophthalmic Ultrasound Systems Market
• Spain Ophthalmic Ultrasound Systems Market
• Rest of Europe Ophthalmic Ultrasound Systems Market
• Asia-Pacific Ophthalmic Ultrasound Systems Market
• China Ophthalmic Ultrasound Systems Market
• Japan Ophthalmic Ultrasound Systems Market
• India Ophthalmic Ultrasound Systems Market
• Australia Ophthalmic Ultrasound Systems Market
• South Korea Ophthalmic Ultrasound Systems Market
• Rest of Asia-Pacific Ophthalmic Ultrasound Systems Market
• Rest of the World Ophthalmic Ultrasound Systems Market
• South America Ophthalmic Ultrasound Systems Market
• Middle East Ophthalmic Ultrasound Systems Market
• Africa Ophthalmic Ultrasound Systems Market

Impact Analysis

AI-Powered Innovations and Applications:

The integration of AI into ophthalmic ultrasound devices is not just a trend; it's a transformative force reshaping the market and redefining the capabilities of the technology. Its impact is felt across multiple aspects, from democratizing access to improving diagnostic accuracy and streamlining clinical workflows.

1. Democratization of Ophthalmic Ultrasound: Traditionally, ophthalmic ultrasound required a highly skilled and experienced operator to obtain diagnostic-quality images. AI-powered innovations are breaking down this barrier. AI-guided ultrasound systems, through real-time feedback and step-by-step instructions, can guide a user with limited experience to capture optimal images. This is particularly impactful for Point-of-Care Ultrasound (POCUS) applications in emergency rooms, primary care offices, and mobile clinics, where a specialist may not be available. The Bill & Melinda Gates Foundation, for instance, is supporting the development of portable, AI-enabled ultrasound devices to aid in maternal health in low-resource settings, illustrating this shift towards wider accessibility.

2. Enhanced Diagnostic Accuracy and Efficiency: AI algorithms, trained on vast datasets of ultrasound images, can automatically detect, segment, and characterize anatomical structures and pathologies. This dramatically improves diagnostic accuracy, often reaching or even exceeding the performance of human experts in detecting conditions like retinal detachment, vitreous hemorrhage, and intraocular tumors. Moreover, AI can automate measurements, such as axial length for IOL calculations, reducing the time and potential for human error. This not only streamlines the diagnostic process but also allows ophthalmologists to focus on more complex cases and patient-centric care.

3. Workflow Optimization and Automation: AI is automating many routine tasks that are time-consuming and labor-intensive. It can assist in image reconstruction, denoising, and enhancement to improve overall image quality. AI-powered systems can also generate automated reports from B-scan images and provide intelligent decision support, helping to standardize diagnostic content and reduce the workload on clinicians. This allows for faster patient throughput and more efficient allocation of healthcare resources.

4. Predictive Analytics and Personalized Care: Beyond diagnosis, AI is beginning to play a role in predicting disease progression and personalizing treatment plans. By analysing a combination of ultrasound data, patient history, and other clinical information, AI models can forecast how a condition may evolve. This capability allows ophthalmologists to make more informed decisions and recommend tailored interventions, leading to better patient outcomes and optimized resource utilization.

5. Fuelling Market Growth and New Opportunities: The incorporation of AI into ophthalmic ultrasound devices is creating a new, high-growth market segment. It is driving research and development, attracting new players, and stimulating strategic partnerships. As AI capabilities advance and regulatory approvals are secured, these intelligent systems will become a new standard of care, further boosting market expansion and pushing the boundaries of what's possible in ophthalmic diagnostics.

U.S. Tariff Impact Analysis on the Ophthalmic Ultrasound Systems Market:

The U.S. tariffs have significantly impacted the global ophthalmic ultrasound systems market by increasing manufacturing costs and putting upward pressure on prices for end-users, potentially slowing market adoption. The tariffs have forced companies to restructure their complex supply chains, leading to costly and time-consuming efforts to diversify production away from high-tariff regions. While some domestic U.S. manufacturers may gain a competitive advantage, the overall effect is a disruption to global trade, a potential decline in profit margins, and a possible slowdown in the pace of innovation as companies divert funds from R&D to manage operational and financial pressures.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Ophthalmic Ultrasound Systems market report study

• Market size analysis for the current ophthalmic ultrasound systems market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the ophthalmic ultrasound systems market.
• Various opportunities available for the other competitors in the ophthalmic ultrasound systems market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current ophthalmic ultrasound systems market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the ophthalmic ultrasound systems market growth in the future?

Frequently Asked Questions for the Ophthalmic Ultrasound Systems Market

1. What is the growth rate of the ophthalmic ultrasound systems market?

• The ophthalmic ultrasound systems market is estimated to grow at a CAGR of 5.28% during the forecast period from 2025 to 2032.

2. What is the market for ophthalmic ultrasound systems?

• The ophthalmic ultrasound systems market was valued at USD 612.48 million in 2024, and is expected to reach USD 918.54 million by 2032.

3. Which region has the highest share in the ophthalmic ultrasound systems market?

• The North America ophthalmic ultrasound systems market is a dominant force globally, driven by the high prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy, coupled with a rapidly aging population. Strong healthcare infrastructure, widespread adoption of advanced diagnostic technologies, and favourable reimbursement policies further support market expansion. Additionally, the presence of leading medical device manufacturers and increasing demand for early, accurate diagnosis of vision-related diseases are driving growth in the region.

4. What are the drivers for the ophthalmic ultrasound systems market?

• The ophthalmic ultrasound systems market is growing due to the rising prevalence of eye disorders like cataracts, glaucoma, and retinal diseases, especially in the aging population. Advancements in portable devices, high-resolution imaging, and AI integration are boosting adoption for accurate, minimally invasive diagnostics. Additionally, expanding healthcare access in emerging economies and increasing routine eye screenings are further driving market demand.

5. Who are the key players operating in the ophthalmic ultrasound systems market?

• Some of the key market players operating in the ophthalmic ultrasound systems market are Sonomed Escalon, Lumibird Medical, DGH Technology, Inc., NIDEK CO., LTD., Topcon Corporation, Accutome Inc., Appasamy Associates Private Limited, Eye-Tech Inc., Micro Medical Devices (MMD), Inc., TOMEY CORPORATION., MEDA Co., Ltd., and Others.

Table of Contents

1. Ophthalmic Ultrasound Systems Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Ophthalmic Ultrasound Systems Market Executive Summary

• 2.1 Market at Glance

3. Ophthalmic Ultrasound Systems Market Key Factors Analysis

• 3.1 Ophthalmic Ultrasound Systems Market Drivers
  • 3.1.1 Rising Prevalence of Ocular Diseases
  • 3.1.2 Expanding Geriatric Population
  • 3.1.3 Technological Advancements
  • 3.1.4 Growing demand for Ocular Biometry
• 3.2 Ophthalmic Ultrasound Systems Market Restraints and Challenges
  • 3.2.1 High Cost of Ophthalmic Ultrasound Systems
  • 3.2.2 Availability of Alternative Diagnostic Technologies
• 3.3 Ophthalmic Ultrasound Systems Market Opportunity
  • 3.3.1 Incorporating artificial intelligence and machine learning to enhance image interpretation

4. Impact Analysis

• 4.1 AI-Powered Innovations and Applications
• 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

• 5.1 The United States
• 5.2 Europe
• 5.3 Japan
• 5.4 China

6. Ophthalmic Ultrasound Systems Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Ophthalmic Ultrasound Systems Market Assessment

• 7.1 By Product
  • 7.1.1 A-scan
  • 7.1.2 B-scan
  • 7.1.3 Combined
  • 7.1.4 Pachymeter
  • 7.1.5 Ultrasound Bio microscope
• 7.2 By Modality
  • 7.2.1 Portable
  • 7.2.2 Standalone
• 7.3 By End-Users
  • 7.3.1 Hospitals
  • 7.3.2 Ambulatory Surgical Centers
  • 7.3.3 Specialty Clinics
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 United States Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.1.2 Canada Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.1.3 Mexico Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
  • 7.4.2 Europe
    • 7.4.2.1 France Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.2.2 Germany Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.2.3 United Kingdom Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.2.4 Italy Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.2.5 Spain Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.2.6 Rest of Europe Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 China Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.3.2 Japan Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.3.3 India Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.3.4 Australia Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.3.5 South Korea Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.3.6 Rest of Asia-Pacific Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 Middle East Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.4.2 Africa Ophthalmic Ultrasound Systems Market Size in USD million (2022-2032)
    • 7.4.4.3 South America Ophthalmic Ultrasound Systems Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Ophthalmic Ultrasound Systems Market Company and Product Profiles

• 10.1 Sonomed Escalon
  • 10.1.1 Company Overview
  • 10.1.2 Company Snapshot
  • 10.1.3 Financial Overview
  • 10.1.4 Product Listing
  • 10.1.5 Entropy
• 10.2 Lumibird Medical
  • 10.2.1 Company Overview
  • 10.2.2 Company Snapshot
  • 10.2.3 Financial Overview
  • 10.2.4 Product Listing
  • 10.2.5 Entropy
• 10.3 DGH Technology, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Snapshot
  • 10.3.3 Financial Overview
  • 10.3.4 Product Listing
  • 10.3.5 Entropy
• 10.4 NIDEK CO., LTD.
  • 10.4.1 Company Overview
  • 10.4.2 Company Snapshot
  • 10.4.3 Financial Overview
  • 10.4.4 Product Listing
  • 10.4.5 Entropy
• 10.5 Topcon Corporation
  • 10.5.1 Company Overview
  • 10.5.2 Company Snapshot
  • 10.5.3 Financial Overview
  • 10.5.4 Product Listing
  • 10.5.5 Entropy
• 10.6 Accutome Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Snapshot
  • 10.6.3 Financial Overview
  • 10.6.4 Product Listing
  • 10.6.5 Entropy
• 10.7 Appasamy Associates Private Limited
  • 10.7.1 Company Overview
  • 10.7.2 Company Snapshot
  • 10.7.3 Financial Overview
  • 10.7.4 Product Listing
  • 10.7.5 Entropy
• 10.8 Eye-Tech Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Snapshot
  • 10.8.3 Financial Overview
  • 10.8.4 Product Listing
  • 10.8.5 Entropy
• 10.9 Micro Medical Devices (MMD), Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Snapshot
  • 10.9.3 Financial Overview
  • 10.9.4 Product Listing
  • 10.9.5 Entropy
• 10.10 TOMEY CORPORATION.
  • 10.10.1 Company Overview
  • 10.10.2 Company Snapshot
  • 10.10.3 Financial Overview
  • 10.10.4 Product Listing
  • 10.10.5 Entropy
• 10.11 MEDA Co., Ltd.
  • 10.11.1 Company Overview
  • 10.11.2 Company Snapshot
  • 10.11.3 Financial Overview
  • 10.11.4 Product Listing
  • 10.11.5 Entropy
• 10.12 Shenzhen Ricso Technology Co., Ltd
  • 10.12.1 Company Overview
  • 10.12.2 Company Snapshot
  • 10.12.3 Financial Overview
  • 10.12.4 Product Listing
  • 10.12.5 Entropy
• 10.13 Sonoscanner
  • 10.13.1 Company Overview
  • 10.13.2 Company Snapshot
  • 10.13.3 Financial Overview
  • 10.13.4 Product Listing
  • 10.13.5 Entropy
• 10.14 Chengdu Healson Technology Co., Ltd
  • 10.14.1 Company Overview
  • 10.14.2 Company Snapshot
  • 10.14.3 Financial Overview
  • 10.14.4 Product Listing
  • 10.14.5 Entropy
• 10.15 Healcerion Co., Ltd
  • 10.15.1 Company Overview
  • 10.15.2 Company Snapshot
  • 10.15.3 Financial Overview
  • 10.15.4 Product Listing
  • 10.15.5 Entropy
• 10.16 Exact Imaging
  • 10.16.1 Company Overview
  • 10.16.2 Company Snapshot
  • 10.16.3 Financial Overview
  • 10.16.4 Product Listing
  • 10.16.5 Entropy
• 10.17 ECHO-SON S.A.
  • 10.17.1 Company Overview
  • 10.17.2 Company Snapshot
  • 10.17.3 Financial Overview
  • 10.17.4 Product Listing
  • 10.17.5 Entropy
• 10.18 Xindray Medical International Co., Ltd
  • 10.18.1 Company Overview
  • 10.18.2 Company Snapshot
  • 10.18.3 Financial Overview
  • 10.18.4 Product Listing
  • 10.18.5 Entropy
• 10.19 KOELIS
  • 10.19.1 Company Overview
  • 10.19.2 Company Snapshot
  • 10.19.3 Financial Overview
  • 10.19.4 Product Listing
  • 10.19.5 Entropy
• 10.20 Interson Corporation
  • 10.20.1 Company Overview
  • 10.20.2 Company Snapshot
  • 10.20.3 Financial Overview
  • 10.20.4 Product Listing
  • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us